Dear Editor, Invasive fungal sinusitis is a rare, severe infection, typically occurring in immunocompromised patients who have impaired neutrophil function or who have received longterm immunosuppressive therapy [1] . Haematological patients and among them, those affected by acute leukaemia and myelodysplastic syndrome are at higher risk [2] . The occurrence of this complication often compromises the therapeutic programme for the underlying haematological condition, necessitating a delay or cessation of chemotherapy with a subsequent high risk of relapse or progression. The acute fulminant form is characterised by its speed of evolution and is associated with a high mortality rate that reaches 100% in cases of intracranial mycotic dissemination [3] . The clinical onset is generally subtle and insidious; facial swelling or pain with or without fever must be promptly considered as possible signs of invasive sinusitis. Computed tomography (CT) evidence of pronounced thickening of the mucosa of the nasal cavity strongly suggests the diagnosis, which can be confirmed by identification of the pathogenic fungus in sinus tissues. Surgical debridement of the affected sinus is a necessary diagnostic and therapeutic procedure and must be combined with systemic antifungal therapy. The fungi most frequently involved are Aspergillus and Zygomicetes. Prognosis is related to various factors, such as the speed of diagnosis and treatment, the type of fungal infection [3] , dissemination to the central nervous system, and complete neutrophil recovery [4] . The scarce information in the literature on invasive fungal sinusitis in immunocompromised patients highlights the importance and efficacy of a combined surgical and medical approach [5] . However, the factors with a major role in the evolution of the infection have not been discussed.
We describe here seven cases of invasive fungal sinusitis, observed at our institution between November 2006 and December 2008, in patients affected by acute leukaemia (five patients with acute myeloid leukaemia and two with acute lymphoblastic leukaemia). These seven cases occurred among a total of 130 patients with acute leukaemia newly diagnosed in the same period. Table 1 summarises the characteristics of these seven patients and their infections. In all cases, the infection developed while the patients were severely neutropenic (neutrophil count< 500/mmc); the neutropenia was chemotherapy-related in six patients, while in one case of acute leukaemic transformation of a myelodysplastic syndrome, it was an expression of the patient's haematological disease. This last patient had never been treated before; two out of the other six patients had received only induction chemotherapy, while the other four patients had a prior history of more chemotherapy (1-8 lines of chemotherapy). Facial pain with or without facial swelling was the initial symptom in all cases, associated with fever in six out of the seven patients. CT scanning, which were performed in an average of 2 days (range, 1-6 days) after the occurrence of the symptoms, revealed, in all cases, unilateral paranasal sinus involvement with opacification and hyperplastic mucosa. Figure 1 shows an exemplary CT scan of the paranasal sinuses, revealing hyperplasia of the right maxillary and ethmoidal mucosa. In two cases, osteolysis of the maxillary and ethmoidal walls was present, and in one case, the CT scan revealed necrotic lesions of the hard palate and turbinates. Prompt endoscopic evaluation confirmed the radiological suspicion of an invasive sinus infection by the finding of friable and ischaemic or necrotic sinus mucosa. Figure 2 shows an endoscopic view of the right nasal fossa through a 0°angled scope; the middle turbinate and mucosa of the lateral wall have a necrotic appearance.
Microbiological analysis of biopsy specimens revealed the presence of Aspergillus in five cases, Mucor in one, and B-ALL B cell acute lymphocytic leukaemia, AML acute myeloid leukaemia, MDS myelodysplastic syndrome, AmBlipo liposomal amphotericin B, Vor voriconazole, Pos posaconazole, Itra itraconazole, ND not done, G-CSF granulocyte colony-stimulating factor a Neutropenia<500/mmc Fig. 2 Endoscopic view of the right nasal fossa through a 0°angled scope: necrotic appearance of the middle turbinate and mucosa of the lateral wall Fig. 1 Coronal computer tomography scan of the paranasal sinuses revealing hyperplasia of the right maxillary and ethmoidal mucosa both Mucor and Fusarium in one. Galactomannan antigen was detected in three patients, and concomitant mycotic lung nodules were found by thoracic CT in three patients. Five out of the seven patients underwent surgical endoscopic debridement of necrotic tissues; no haemorrhagic complications occurred despite severe thrombocytopenia. Four patients promptly started treatment with liposomal amphotericin B (AmBlipo) and were given systemic voriconazole as recommended after Aspergillus had been identified [6] . One patient received voriconazole as firstline therapy, another was treated first with itraconazole and then, because of progression, with AmBlipo, and the remaining patient received posaconazole because of persistent fever despite treatment with AmBlipo. Among the five patients treated with combined medical and surgical therapy, two died of progressive infection, 18 and 44 days after the diagnosis, in a phase of persistent neutropenia; while, in the other three patients, the mycosis improved substantially after complete neutrophil recovery, and CT scans performed after 30-45 days documented resolution of the radiological signs of infection. Of the two patients treated only with systemic antifungal therapy, one died 16 days after diagnosis in a phase of blastic evolution of acute leukaemia, while the other case recovered, although the mucormycosis had extended to the cavernous sinus causing occlusion of the carotid artery with consequent ischaemic cerebral lesions responsible for hemiplegia. This patient received AmBlipo followed by posaconazole and although no surgical treatment was performed, a clinical improvement was observed when the neutrophil count increased, heralding complete remission of the acute leukaemia. Unlike the patients described by Vener et al. [5] , our cases were all neutropenic at the onset of infection and mycosis resolved only in those in whom neutrophils reappeared, suggesting that medical and surgical efforts are useful and necessary, but not sufficient if the underlying leukocyte impairment persists. Neutrophil transfusions could represent a therapeutic option in these cases in order to support treatment before haematological recovery [7] , but are still a complex procedure without clear and documented advantages in patients with long-lasting neutropenia.
In conclusion, our experience in severely neutropenic patients confirms the following: (a) the importance of careful and swift recognition of initial signs of sinusitis followed by a prompt otorhinolaryngoiatric intervention to confirm the diagnostic suspicion and to remove infected tissues; (b) that surgery is effective and safe also in thrombocytopenic patients; and (c) that the recovery of a normal neutrophil count is essential for a positive evolution of the infection and therefore, represents a crucial prognostic factor.
